Distinguished in Spasmodic Dysphonia

Kiyohito Hosokawa

Department Of Otorhinolaryngology Head And Neck Surgery, 2-2 Yamadaoka, 
Suita, JP 
Distinguished in Spasmodic Dysphonia
Department Of Otorhinolaryngology Head And Neck Surgery, 2-2 Yamadaoka, 
Suita, JP 
OverviewLocationsClinical Research

Overview

Kiyohito Hosokawa practices in Suita, Japan. Hosokawa is rated as a Distinguished expert by MediFind in the treatment of Spasmodic Dysphonia. Their top areas of expertise are Spasmodic Dysphonia, Chronic Rhinosinusitis with Nasal Polyps (CRSwNP), Aphthous Stomatitis, and Canker Sore.

Their clinical research consists of co-authoring 44 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 14 articles in the study of Spasmodic Dysphonia.

Locations

Department Of Otorhinolaryngology Head And Neck Surgery, 2-2 Yamadaoka, Suita, 5650871, Japan
Other Locations
Department Of Otorhinolaryngology And Head & Neck Surgery, Osaka, Japan
Sendai, 9808578, Japan
Head And Neck Surgery, Toyonaka, Japan

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Randomised, Double-blind, Placebo Controlled, Parallel Group Phase III Study to Assess the Clinical Efficacy and Safety of 100 mg SC Mepolizumab in Adults With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) / Eosinophilic Chronic Rhinosinusitis (ECRS) MERIT: Mepolizumab in Eosinophilic Chronic RhinosinusITis Study
A Randomised, Double-blind, Placebo Controlled, Parallel Group Phase III Study to Assess the Clinical Efficacy and Safety of 100 mg SC Mepolizumab in Adults With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) / Eosinophilic Chronic Rhinosinusitis (ECRS) MERIT: Mepolizumab in Eosinophilic Chronic RhinosinusITis Study
Enrollment Status: Completed
Publish Date: November 25, 2024
Intervention Type: Drug
Study Drugs: Mepolizumab, Standard of Care
Study Phase: Phase 3

44 Total Publications

Letter to the Editor: "Effects of Silent Segment Processing on Cepstral Measures in Japanese Voice Assessment: A Reliability and Perceptual Correlation Study" by Kodama et al, In Press in Journal of Voice.
Letter to the Editor: "Effects of Silent Segment Processing on Cepstral Measures in Japanese Voice Assessment: A Reliability and Perceptual Correlation Study" by Kodama et al, In Press in Journal of Voice.
Journal: Journal of voice : official journal of the Voice Foundation
Published: August 21, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Hosokawa's expertise for a condition
ConditionClose
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile